HemaSphere (Jun 2022)

PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.

  • D. Christopher,
  • N. A. Abdul Halim,
  • C. A. Gallardo,
  • G. H. Lim,
  • W. Y. Jen,
  • C. Y. Lin,
  • E. F. Bingwen,
  • M. Ooi,
  • Y. L. Chee,
  • V. S. Sampath,
  • G. C. Wong

DOI
https://doi.org/10.1097/01.HS9.0000850104.80221.19
Journal volume & issue
Vol. 6
pp. 1693 – 1694

Abstract

Read online

No abstracts available.